Helus Pharma: Wells Fargo raises target price to $22 from $16
HELP•Wells Fargo raised its target price for Helus Pharma to $22 from $16.
Related News
Ategrity Specialty Insurance Company Holdings: Barclays cuts target price to $27 from $28
ASIC•
Eloxx Pharmaceuticals appoints Geno J. Germano to board
ELOX•
Utility PG&E falls on Q3 profit miss
PCG•
Darling Ingredients forecasts 2026 combined adjusted EBITDA of $2.2 billion-$2.3 billion
DAR•
Irish central bank fines Coinbase unit €3.25 million
COIN•